Morgan Stanley’s NeuroDerm Ltd. Ordinary Shares NDRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-950
| Closed | -$37K | – | 6911 |
|
|
2017
Q3 | $37K | Sell |
950
-10,132
| -91% | -$395K | ﹤0.01% | 5876 |
|
|
2017
Q2 | $332K | Sell |
11,082
-2,957
| -21% | -$88.6K | ﹤0.01% | 5045 |
|
|
2017
Q1 | $373K | Sell |
14,039
-460
| -3% | -$12.2K | ﹤0.01% | 5010 |
|
|
2016
Q4 | $323K | Sell |
14,499
-605
| -4% | -$13.5K | ﹤0.01% | 5156 |
|
|
2016
Q3 | $279K | Sell |
15,104
-2,578
| -15% | -$47.6K | ﹤0.01% | 4847 |
|
|
2016
Q2 | $287K | Sell |
17,682
-399
| -2% | -$6.48K | ﹤0.01% | 4754 |
|
|
2016
Q1 | $256K | Sell |
18,081
-34,391
| -66% | -$487K | ﹤0.01% | 4840 |
|
|
2015
Q4 | $895K | Buy |
52,472
+18,910
| +56% | +$323K | ﹤0.01% | 4136 |
|
|
2015
Q3 | $694K | Buy |
33,562
+25,467
| +315% | +$527K | ﹤0.01% | 4389 |
|
|
2015
Q2 | $125K | Buy |
8,095
+4,895
| +153% | +$75.6K | ﹤0.01% | 5474 |
|
|
2015
Q1 | $43K | Sell |
3,200
-6,074
| -65% | -$81.6K | ﹤0.01% | 5851 |
|
|
2014
Q4 | $130K | Buy |
+9,274
| New | +$130K | ﹤0.01% | 5435 |
|